scott kopetz, md, phd, facp, considers the addition of vemurafenib to the nccn guidelines for mcrc
Published 6 years ago • 17 plays • Length 0:23
Download video MP4
Download video MP3
Similar videos
-
0:30
scott kopetz, md, phd, facp, explains how nivolumab is being incorporated into mcrc treatment
-
0:57
scott kopetz, md, phd, facp, on the potential of binimetinib immunotherapy in mcrc patients
-
0:38
scott kopetz, md, phd, facp, discusses the incidence of braf mutation in crc patients
-
1:01
scott kopetz, md, phd, facp, regarding molecular profile matching in trials with mcrc patients
-
1:59
scott kopetz, md, phd, facp, on the implications of the beacon phase 3 study in braf-mutant mcrc
-
0:54
dr. kopetz on safety data from beacon crc trial in braf v600e-mutant mcrc
-
1:06
scott kopetz, md, explains how braf mutations figure into treatment algorithms for crc
-
1:54
dr. kopetz on the rationale and primary endpoints of the beacon crc study in mcrc
-
50:21
infectious diseases - march weekly webinar copm 2022
-
25:06
colorectal cancer: sequencing and therapeutic approaches in first- and next-line treatment
-
1:34
copan
-
1:34
dr. kopetz on the biology of right- versus left-sided crc
-
1:44
dr. kopetz discusses the treatment of braf-mutant crc
-
2:21
meet gastrointestinal medical oncologist scott kopetz, m.d., ph.d.
-
1:38
dr. kopetz on the correlation between tumor sidedness and biomarkers in crc
-
1:39
dr. kopetz on the significance of tumor sidedness in crc
-
1:14
dr. kopetz on the importance of molecular testing in crc
-
32:43
colorectal cancer and immunotherapy with dr. scott kopetz
-
4:11
continuum of care in metastatic colorectal cancer
-
1:08
dr. doug potoczak
-
1:13:25
prof eric van cutsem, md & scott kopetz, md discuss colorectal cancer: https://bit.ly/3vfphkp
-
3:01
mayo clinic cancer center - thoracic oncology update by tobias peikert, md | preview
Clip.africa.com - Privacy-policy